ARTICLE | Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
February 24, 2014 8:00 AM UTC
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) rose $1.21 (24%) to $6.16 on Wednesday after FDA granted accelerated approval to Northera droxidopa to treat neurogenic orthostatic hypotension (NOH). The company plans to launch Northera next half.
Chelsea finished the week up $1.31 (28%) to $6.04...